GeMoA

The GeMoA consortium, composed by four academic research groups and one company from three European countries are joining efforts with the broad aim of integrating computational and experimental approaches into an innovative platform for genome-wide characterization of the mechanism-of-action for selected chemical compounds with activity against Mycobacterium tuberculosis.